Alicia Wilkerson
Family Medicine · Arlington, TXNPI 1902937808
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations.
Across 228 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$810
- Lilly USA, LLC$520
- GSK$497
- Novo Nordisk$322
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$305
- Abbott$255
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,767100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $810 |
| Lilly USA, LLC | 30 | $520 |
| GSK | 23 | $497 |
| Novo Nordisk | 20 | $322 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $305 |
| Abbott | 9 | $255 |
| AstraZeneca | 15 | $248 |
| Pfizer | 8 | $140 |
| Genentech USA, Inc. | 9 | $126 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $58 |
| Shield Therapeutics Inc | 3 | $56 |
| Johnson & Johnson | 4 | $54 |
| Exact Sciences | 3 | $51 |
| Paratek Pharmaceuticals, Inc. | 3 | $46 |
| Biohaven Pharmaceuticals, Inc. | 3 | $45 |
| CSL Behring | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $20 |
| Metuchen Pharmaceuticals | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Lupin Inc. | 1 | $16 |
| Amgen | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $12 |
| Nabriva Therapeutics, PLC | 1 | $12 |
| Athena Bioscience, LLC | 1 | $11 |
| Currax Pharmaceuticals LLC | 1 | $11 |
| Merck | 1 | $11 |
How this compares
$3,767 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 57 | $1,628 |
| Ventolin HfaAlbuterol Sulfate | 22 | $1,455 |
| Montelukast Sodium | 23 | $414 |
| Amlodipine Besylate | 27 | $306 |
| Naproxen | 17 | $262 |
| Lisinopril | 27 | $253 |
| Ciprofloxacin Hcl | 18 | $206 |
| Pantoprazole Sodium | 12 | $199 |
| Prednisone | 61 | $189 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 17 | $188 |
| Metoprolol Succinate | 20 | $172 |
| Azithromycin | 46 | $163 |
| Levothyroxine Sodium | 24 | $155 |
| Hydrochlorothiazide | 12 | $81 |
| Citalopram HbrCitalopram Hydrobromide | 16 | $59 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Arlington
- Bradley WassonArlington$734K
- Gilbert LedesmaArlington$34K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.